In the modern view of selective drug delivery of bioactive molecules, the attention is moving onto the setup of the perfect carrier more than in the optimization of the active compound. In this respect, virus-like particles constitute bioinspired nanodevices with the intrinsic ability to transport a large class of molecules, ranging from smart drugs to small interfering RNAs. In this work, we demonstrate the efficacy of a novel construct obtained by fusing a self-assembling protein from the human Rotavirus A, VP6, with the Small Ubiquitin Modifier domain, which maintains the ability to form nanoparticles and nanotubes and is able to be used as a drug carrier, even without specific targeting epitopes. The high expression and purification yield, combined with low toxicity of the empty particles, clearly indicate a good candidate for future studies of selective drug delivery. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 2018.

Amalfitano, A., Martini, C., Nocca, G., Papi, M., De Spirito, M., Sanguinetti, M., Vitali, A., Bugli, F., Arcovito, A., A protein chimera self-assembling unit for drug delivery, <<BIOTECHNOLOGY PROGRESS>>, 2019; 35 (2): N/A-N/A. [doi:10.1002/btpr.2769] [http://hdl.handle.net/10807/129550]

A protein chimera self-assembling unit for drug delivery

Amalfitano, Adriana;Martini, Cecilia;Nocca, Giuseppina;Papi, Massimiliano;De Spirito, Marco;Sanguinetti, Maurizio;Vitali, Alberto;Bugli, Francesca;Arcovito, Alessandro
2019

Abstract

In the modern view of selective drug delivery of bioactive molecules, the attention is moving onto the setup of the perfect carrier more than in the optimization of the active compound. In this respect, virus-like particles constitute bioinspired nanodevices with the intrinsic ability to transport a large class of molecules, ranging from smart drugs to small interfering RNAs. In this work, we demonstrate the efficacy of a novel construct obtained by fusing a self-assembling protein from the human Rotavirus A, VP6, with the Small Ubiquitin Modifier domain, which maintains the ability to form nanoparticles and nanotubes and is able to be used as a drug carrier, even without specific targeting epitopes. The high expression and purification yield, combined with low toxicity of the empty particles, clearly indicate a good candidate for future studies of selective drug delivery. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 2018.
Inglese
http://onlinelibrary.wiley.com/journal/10.1021/(ISSN)1520-6033
Amalfitano, A., Martini, C., Nocca, G., Papi, M., De Spirito, M., Sanguinetti, M., Vitali, A., Bugli, F., Arcovito, A., A protein chimera self-assembling unit for drug delivery, <>, 2019; 35 (2): N/A-N/A. [doi:10.1002/btpr.2769] [http://hdl.handle.net/10807/129550]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/129550
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact